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Background: Race and gender have individually been associated with affecting outcomes in vascular interventions. We hy-
pothesized that raceandgenderstratiﬁcationwould identify variations inoutcomesof lowerextremitybypass (LEB)procedures.
Methods: LEB procedures were identiﬁed using Current Procedural Terminology (American Medical Association,
Chicago, Ill) codes from the 2011 American College of Surgeons National Surgical Quality Improvement Program
database. Individuals of races other than black or white were excluded because of small sample size. Preoperative variables,
such as age, demographics, medical comorbidities, and laboratory values, were evaluated across race and gender groups
using c2, the Student t-test, and least square means testing. Signiﬁcant predictors were entered into a multivariate logistic
regression model. Six primary outcomes were evaluated: major complications, minor complications, 30-day mortality,
early graft failure, readmission, and length of stay (LOS).
Results: There were 4518 LEB procedures performed on black (n[ 839; male [BM], 56.5%; female [BF], 43.5%) or white
(n [ 3679; male [WM], 66.4%; female [WF], 33.6%) patients. Black patients were more likely to be younger, diabetic,
smokers, functionally dependent, dialysis dependent, and have hypertension, critical limb ischemia, higher creatinine, lower
hematocrits, andhigher platelet counts.Multivariate analysis revealed no statistically signiﬁcant gender differenceswithin the
white cohort with respect to complications, death, graft failure, or readmission rates. WF and BMhad longer LOS thanWM
(reference group; 4.7 6 1.9 days and 5.4 6 2.0 days vs 4.3 6 2.0 days, respectively; P < .006 and P < .0001) after LEB
procedures, but outcomes among these groups did not differ signiﬁcantly. BF had a longer LOS thanWM (5.86 2.0 days vs
4.362.0days;P< .0001) and trended towardhigher readmission rates (odds ratio, 1.28; 95%conﬁdence interval, 0.97-1.70;
P[ .08).BFhadahigher risk of early graft failure thanWM(odds ratio, 2.90; 95%conﬁdence interval, 1.52-5.49;P[ .001).
Conclusions: BF had higher early graft failure and LOS compared withWM.WF and BM also had increased LOS compared
with WM. Race-gender stratiﬁcation may predict outcomes in patients undergoing LEB procedures that may not be pre-
dicted by gender or race alone. Further studies using this stratiﬁcationmethodologymay provide better insight into optimal
therapeutic strategies and preventative measures for these patient subgroups. Investigation into causes of increased LOS in
black patients and increased graft failure in BF may help improve outcomes. (J Vasc Surg 2014;60:1275-81.)Population-based analyses have demonstrated that the
prevalence of peripheral arterial disease (PAD) in the
United States is on the rise, particularly as the population
continues to age.1-3 Open surgical bypass is an important
method of revascularization in patients with chronic limb
ischemia. Technical factors are an important determinant
of early outcomes in lower extremity bypass (LEB); howev-
er, comorbid conditions, progression of disease, demo-
graphics, and clinical presentation, have been shown to
play a role as well. Although some predictors of outcomes
after surgical intervention for PAD have been established,
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://dx.doi.org/10.1016/j.jvs.2014.04.069There is some controversy in literature on the effect of
black race on morbidity and mortality after LEB. Studies
on the effect of gender on LEB are also inconclusive. Recent
outcomes-based analyses have evaluated female gender4-11
and black race12-14 as independent predictors of periopera-
tive morbidity after infrainguinal bypass procedures. Yet,
there is a relative scarcity of literature examining race and
gender together as risk factors for adverse events after
LEB. A 2009 study by Nguyen et al15 examined the interac-
tions between race and gender in their effect on graft
patency, limb loss, and mortality after LEB for patients
with chronic limb ischemia. Using white men as a reference
group, they concluded there was a synergistic correlation be-
tween race and gender, ﬁnding that black men had an
increased risk of perioperative (30-day) graft failure and
that black women had an increased risk of graft failure at
1 year.
Given these disparate reports in the literature, we
aimed to clarify the effect of gender and race stratiﬁcation
on perioperative outcomes after LEB.
METHODS
The Institutional Review Board at the University of
North Carolina-Chapel Hill approved this study and
waived informed consent because it was a retrospective re-
view from a deidentiﬁed database.1275
Table I. Current Procedural Terminology (CPT)a codes and descriptions used to identify extremity bypass procedures
Code Description
35556 Femoral-popliteal bypass graft with vein
35566 Femoral-anterior tibial/posterior tibial/peroneal bypass graft with vein
35571 Popliteal-tibial/peroneal bypass graft with vein
35583 Femoral-popliteal in-situ vein bypass
35585 Femoral-anterior tibial/posterior tibial/peroneal in-situ vein bypass
35587 Popliteal-tibial/peroneal in-situ vein bypass
35656 Femoral-popliteal bypass graft with other than vein
35666 Femoral-anterior tibial/posterior tibial/peroneal bypass graft with other than vein
35671 Popliteal-tibial/peroneal bypass graft with other than vein
aAmerican Medical Association, Chicago, Ill.
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(CPT) codes (American Medical Association, Chicago,
Ill) from the 2011 American College of Surgeons National
Surgical Quality Improvement Program (NSQIP) Partici-
pant Users File to identify LEB procedures. NSQIP is a
prospective database that monitors postoperative outcomes
in the 30 days after major surgical procedures. The data-
base also includes information on demographics, preopera-
tive risk factors, and intraoperative variables.
Eligibility. All patients undergoing major LEB from
January 1, 2011, to December 31, 2011, in the NSQIP
database were eligible for inclusion in our study. Proce-
dures were identiﬁed using CPT codes for major LEB,
including femoral-to-popliteal bypass (35556, 35583,
35656), femoral-to-tibial bypass (35566, 35585, 35666),
and popliteal-to-tibial bypass (35571, 35587, 35671).
Further description of these codes can be found in Table I.
Exclusions. Analyses included patients aged >18 years
because the NSQIP excludes those aged <18 years from
data collection. Individuals of races other than black or
white were also excluded from analyses. These included
those with race listed as unknown or null value (n ¼
413), American Indian or Alaska Native (n ¼ 13), Native
Hawaiian or Paciﬁc Islander (n ¼ 10), and Asian (n ¼ 50).
Preoperative variables. Demographic variables are re-
ported in Table II. Age is truncated at 90 years in the
NSQIP data set. Smoking was deﬁned as having smoked in
the year before admission (yes/no). Patients with insulin or
noninsulin-dependent diabetes were grouped for analyses.
Functional health status before surgery was categorized as
independent or dependent (partially dependent, fully
dependent). Preoperative albumin, creatinine, and other
relevant laboratory values were evaluated.
Primary outcomes. The primary outcomes evaluated
weremajor andminor complications, death, early graft failure,
readmission, and length of stay (LOS). Major complications
included renal failure, pulmonary embolism, stroke, cardiac
arrest, and myocardial infarction. Minor complications
included superﬁcial or deep wound infections, dehiscence,
pneumonia, acute kidney injury, urinary tract infection, nerve
injury, deep vein thrombosis, sepsis, and reoperation.
Statistical analysis. Preoperative variables, such as
age, demographics, medical comorbidities, and laboratory
values, were evaluated across race and gender groups usingc2, Student t-test, and least squaremeans testing. Signiﬁcant
predictorswere entered into amultivariate logistic regression
model. Groups were stratiﬁed into whitemales (WM), white
females (WF), black males (BM), and black females (BF).
Multivariate Cox proportional hazard modeling was per-
formed to evaluate odds ratios (ORs) with 95% conﬁdence
intervals (CIs) of primary outcomes. LOS was a nonpara-
metric variable in our data set with positive skewness. As
such, the LOS variable was log (base 10) transformed, and
geometric means with standard deviations were estimated
by race and gender subgroup. Subgroup comparisons were
made using the Wilcoxon-Mann-Whitney test, a nonpara-
metric test for non-normally distributed variables.
Some data points in the categories of peripheral vascular
disease, critical limb ischemia, myocardial infarction, stroke,
and functional status were missing for some patients in this
large database. These missing data were accounted for using
the method of multiple imputations. Each missing value was
replaced with a plausible value for the probability of each co-
morbid condition, rounded to 0 or 1. Fifty imputations were
performed, and results were analyzed using standard statis-
tical methods. All statistical analysis was done using SAS
software (SAS Institute, Cary, NC).
RESULTS
We identiﬁed 4518 LEB procedures from the 2011
NSQIP database, of which 3679 procedures (81.4%)
were performed for white patients and 839 (18.6%) for
black patients. Twice as many procedures were performed
in WM (n ¼ 2444) compared with WF (n ¼ 1235). The
difference between genders was less pronounced between
BM (n ¼ 474) and BF (n ¼ 365).
Preoperative demographics and comorbid conditions
were evaluated by race and gender stratiﬁcation (Table II).
We used a multivariable regression model accounting for
all signiﬁcant demographic differences and comorbid condi-
tions to analyze 30-day outcomes after stratifying data by
race and gender (Tables III and IV). Signiﬁcant variables
included age, diabetes mellitus, smoking history, functional
status, chronic obstructive pulmonary disease, hypertension,
peripheral vascular disease, rest pain at presentation (term in
data set used to identify all patients with critical limb
ischemia), dialysis dependence, preoperative creatinine, al-
bumin level, preoperative hematocrit, preoperative platelet
Table II. Demographic and comorbid conditions by race and gender subgroups
Variablea
P










all strata WF BM BF
Age at procedure, years 66.9 6 12.0 63.8 6 10.7 70.2 6 11.9 67.1 6 10.9 <.001 <.001 <.001 .73
Diabetes
No 198 (54.3) 242 (51.1) 695 (56.3) 1423 (58.2)
Yes 167 (48.8) 232 (48.9) 540 (43.7) 1021 (41.8) .02 .26 .0039 .15
Smoking history
No 211 (57.8) 242 (51.1) 770 (62.4) 1373 (56.2)
Yes 154 (42.2) 232 (48.9) 465 (37.6) 1071 (43.8) <.0001 .0003 .04 .56
Functional status
Independent 314 (86.0) 411 (86.9) 1092 (88.6) 2213 (91.1)
Dependent 51 (14.0) 62 (13.1) 140 (11.4) 216 (8.9) .001 .017 .0044 .002
COPD
No 335 (91.8) 436 (92.0) 1055 (85.4) 2107 (86.2) <.0001 .52 .0006 .003
Yes 30 (8.2) 38 (8.0) 180 (14.6) 337 (13.8)
Congestive heart failure
No 354 (97.0) 459 (96.8) 1214 (98.3) 2379 (97.3) .2 .07 .54 .7
Yes 11 (3.0) 15 (3.2) 21 (1.7) 65 (2.7)
Hypertension
No 35 (9.6) 58 (12.2) 181 (14.7) 410 (16.8) .001 .1 .014 .001
Yes 330 (90.4) 416 (87.8) 1054 (85.3) 2034 (83.2)
Peripheral vascular disease
No 192 (52.5) 236 (49.7) 613 (49.6) 1239 (50.7) .79 .56 .52 .64
Yes 173 (47.5) 238 (50.3) 622 (50.4) 1205 (49.3)
Rest pain
No 195 (53.3) 263 (55.5) 748 (60.6) 1547 (63.3) <.0001 .27 .01 .001
Yes 170 (46.7) 211 (44.5) 487 (39.4) 897 (36.7)
Dialysis
No 322 (88.2) 416 (87.8) 1186 (96.0) 2327 (95.2) <.0001 .26 <.0001 <.0001
Yes 43 (11.8) 58 (12.2) 49 (4.0) 117 (4.8)
Wound infection
No 234 (64.1) 307 (64.8) 783 (63.4) 1648 (67.4) .1 .02 .26 .21
Yes 131 (35.9) 167 (35.2) 452 (36.6) 796 (32.6)
Weight loss
No 362 (99.2) 471 (99.4) 1224 (99.1) 2415 (98.8) .63 .41 .29 .54
Yes 3 (0.8) 3 (0.6) 11 (0.9) 29 (1.2)
Bleeding disorder
No 278 (76.2) 363 (76.6) 933 (75.6) 1810 (74.1) .53 .33 .25 .39
Yes 87 (23.8) 111 (23.4) 302 (23.4) 634 (25.9)
Emergency procedure
No 349 (95.6) 453 (95.6) 1151 (93.2) 2312 (94.6) .12 .1 .39 .42
Yes 16 (4.4) 21 (4.4) 84 (6.8) 132 (5.4)
ASA classiﬁcation
No/mild disturbance 16 (4.4) 30 (6.3) 68 (5.5) 142 (5.8) .64 .7 .67 .27
Severe/life-threatening/moribund 349 (95.6) 444 (93.7) 1167 (94.5) 2302 (94.2)
Creatinine, mg/dL 1.7 6 2.1 1.8 6 2.0 1.1 6 1.1 1.3 6 1.1 <.0001 <.0001 <.0001 <.0001
Albumin, mg/dL 3.4 6 0.6 3.5 6 0.7 3.5 6 0.6 3.6 6 0.7 .0001 .03 .01 <.0001
Albuminuria
<3.0 g/dL albumin 16 (4.4) 30 (6.3) 68 (5.5) 142 (5.8) .7 .9 .99 .15
>3.0 g/dL albumin 349 (95.6) 444 (93.7) 1167 (94.5) 2298 (94.2)
Hematocrit, % 34.3 6 5.3 36.4 6 6.4 35.8 6 5.3 38.4 6 6.2 <.0001 <.0001 <.0001 <.0001
Platelet count, 103/mL 268 6 98 260 6 113 258 6 96 236 6 88 <.0001 <.0001 <.0001 <.0001
INR 1.1 6 0.2 1.1 6 0.2 1.1 6 0.4 1.1 6 0.3 .42 .32 .23 .17
Location of bypass
Proximal 209 (57.3) 221 (46.6) 818 (66.2) 1412 (57.8) <.0001 <.0001 <.0001 .85
Distal 156 (42.7) 253 (53.4) 417 (33.8) 1032 (42.2)
Type of graft
Vein 230 (63.0) 320 (67.5) 742 (60.1) 1667 (68.2) <.0001 <.0001 .77 .05
Prosthetic 135 (37.0) 154 (32.5) 493 (39.9) 777 (31.8)
ASA, American Society of Anesthesiologists; BF, black females; BM, black males; COPD, chronic obstructive pulmonary disease; INR, international
normalized ratio; WF, white females; WM, white males.
aContinuous data are shown as mean 6 standard deviation and categoric data as number (%).
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Table III. Primary outcomes stratiﬁed by race-gender subgroupsa
Outcome BF (n ¼ 365) BM (n ¼ 474) WF (n ¼ 1235)
WM (n ¼ 2444)
Referent group
Complications
Major 0.93 (0.51-1.69) 1.12 (0.67-1.86) 1.19 (0.83-1.69) 1
P NS NS NS
Minor 1.23 (0.96-1.58) 0.95 (0.75-1.20) 1.10 (0.93-1.29) 1
P NS NS NS
Death 1.51 (0.81-2.82) 0.77 (0.36-1.63) 1.18 (0.76-1.84) 1
P NS NS NS
Graft failure 2.90 (1.52-5.49) 1.39 (0.68-2.83) 1.20 (0.67-2.13) 1
P .001 .37 .55
Readmission 1.28 (0.97-1.70) 1.22 (0.94-1.58) 1.09 (0.90-1.32) 1
P .08 .14 .38
LOS, days 5.8 6 2.0 5.4 6 2.0 4.7 6 1.9 4.3 6 2.0
P <.0001 <.0001 .0006
BF, Black females; BM, black males; LOS, length of stay; NS, not signiﬁcant; WF, white females; WM, white males.
aData are presented as the odds ratio (OR; 95% conﬁdence interval [CI]) vs the referent group or as the mean 6 standard deviation vs the referent group.
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graft used (vein or prosthetic).
With WM used as a reference group, Cox proportion
modeling analysis showed no signiﬁcant difference in the
risk of major complications, minor complications, or death
among the race-gender strata (Table III). WF exhibited no
signiﬁcant differences in graft failure or readmission
compared with WM but did have signiﬁcantly longer
LOS than WM (4.7 6 1.9 days vs 4.3 6 2.0 days, P ¼
.0006). BM had a longer LOS (5.4 6 2.0 days vs 4.3 6
2.0 days, P <.0001) than WM. Differences between BM
and WM for outcomes of graft failure and readmission
were not signiﬁcant. BF had a higher risk of graft failure
compared with WM (OR, 2.90; 95% CI, 1.52-5.49; P ¼
.001) and a longer LOS (5.8 6 2.0 days vs 4.3 6
2.0 days; P < .0001); BF also trended toward a higher
risk of readmission #30 days (OR, 1.28; 95% CI, 0.97-
1.70; P ¼ .08). When differences between the two female
subgroups were compared (Table IV), BF had a higher risk
of early graft failure than WF (OR, 2.51; 95% CI, 1.21-
5.21; P ¼ .01), and BF had a longer LOS stay than WF
(5.8 6 2.0 days vs 4.7 6 1.9 days, P < .0001).
DISCUSSION
LEB has been associated with signiﬁcant perioperative
morbidity and mortality.16,17 Much of the literature on
risk factors for negative outcomes after infrainguinal bypass
has examined race and gender as independent variables. We
analyzed perioperative outcomes of LEB procedures for
4518 patients, stratiﬁed into groups by race and gender.
Using WM as our reference group, we found graft fail-
ure #30 days after LEB procedures was more common in
BF but not BM. BF and BM both had a longer LOS post-
operatively compared with WM. BF and BM also trended
toward higher readmission rates than WM, but this was
not statistically signiﬁcant. Although black patients had
signiﬁcantly more comorbidities, the differences in major
complications, minor complications, and mortality among
the race-gender groups were not statistically signiﬁcantafter multivariable regression analysis. Mortality in BF
was almost twice as high as that of BM (OR, 2.50; 95%
CI, 0.91-6.90); however, this did not achieve statistical sig-
niﬁcance (P ¼ .08). The results obtained from the analysis
of our outcomes data were synergistically inﬂuenced by the
effect of both race and gender.
Early graft failure is a devastating complication of
infrainguinal arterial bypass and can be associated with
additional morbidity and mortality. A recent publication
estimated a 5% incidence of early graft failure after arterial
LEB.18 Traditionally, early graft failure has been attributed
to technical factors, such as vein diameter, intimal ﬂap, and
conduit type.19,20
A recent publication by Singh et al21 using the NSQIP
database from 1995 to 2003 identiﬁed nontechnical risk fac-
tors associated with early graft failure after infrainguinal arte-
rial bypass, and black race was one of the associated risk
factors. In a retrospective analysis of 1459 infrainguinal
bypass grafts during an 18-year period, Chew et al12 similarly
identiﬁed that black race was associated with a higher inci-
dence of 30-day graft failure after LEB compared with white
race.12 It is hypothesized that increased severity of arterial
occlusive disease at presentation in black patients22 may
lead to a higher incidence of early graft failure; however,
evidence-based support for this association between black
race and early graft failure has yet to be clearly established.
Interestingly, in our study, black race by itself did not confer
a difference inmortality,minor complications, ormajor com-
plications.BFdidhave a higher incidenceof early graft failure.
Although black race is generally associated with increased
risk of adverse events after LEB surgery,12,18,21,23,24 data on
the effect of female gender on postoperative outcomes after
LEB is less clear. Some studies support an increased risk of
early and late graft failure in women compared with
men,24-26 although other studies have found no difference
in graft patency between men and women.4,10 A recent pub-
lication by Hiramoto et al27 demonstrated that higher levels
of C-reactive protein and ﬁbrinogen in female patients under-
going LEB were associated with increased risk of early graft
Table IV. Outcomes stratiﬁed by black females (BF) and
white females (WF)a
Outcome BF (n ¼ 365)
WF (n ¼ 1235)
Referent group P
Complications
Major 0.71 (0.38-1.36) 1.0 .31
Minor 1.10 (0.83-1.44) 1.0 .52
Death 1.24 (0.63-2.45) 1.0 .54
Graft failure 2.51 (1.21- 5.21) 1.0 .01
Readmission 1.23 (0.91-1.67) 1.0 .19
LOS, days 5.8 6 2.0 4.7 6 1.9 <.0001
LOS, Length of stay.
aData are presented as the odds ratio (OR; 95% conﬁdence interval [CI]) vs
the reference group or as the mean 6 standard deviation vs the reference
group.
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counterparts. Although further research on the matter is
certainly necessary, this described difference in the inﬂamma-
tory makeup of men and women may help inﬂuence surgical
decision making for patients requiring LEB.
In 2009, Nguyen et al15 evaluated patients in the pro-
spective, randomized Project of Ex-Vivo vein graft Engi-
neering via Transfection III (PREVENT III) trial to look
at the interactions between race and gender in their effect
on graft patency, limb loss, and mortality after LEB for pa-
tients with chronic limb ischemia. Their study included
1404 patients divided into four subgroups: black women
(n ¼ 118), black men (n ¼ 131), white women (n ¼
389), and white men (n ¼ 766). Using white men as a
reference group, they concluded there was a synergistic ef-
fect between race and gender, with black men found to
have an increased risk of perioperative graft failure, whereas
black women had an increased risk of graft failure at 1 year.
Our results differed from those described by Nguyen
et al,15 in that BF in our study had a higher incidence of early
graft failure after LEB but BM did not. The PREVENT III
trial was a prospective randomized controlled trial, whereas
our study examined a large retrospective database. The
NSQIP data set only tracks 30-day outcomes, thus we were
unable to analyze outcomes at $1 year using these data.
The difference in our results may also be attributed to the
larger patient sample size inourdata set,which included three
times as many patients as the database used by Nguyen et al,
and more speciﬁcally, three times as many black patients.
Another key difference between our studies was the
eras in which the data were collected. PREVENT III
looked at patients undergoing bypasses between 2001
and 2003 using vein grafts only, whereas data from our
study population were collected 8 years later retrospectively
and included bypasses with vein or prosthetic grafts. Dur-
ing the past decade, treatment of lower extremity PAD
by vascular surgeons has changed signiﬁcantly. Current
LEBs are likely performed on sicker more complicated pa-
tients compared with procedures a decade ago.
Harris et al28 showed that among vascular surgeons be-
tween 2000 and 2007, there had been an increase of
almost 600% in the amount of peripheral interventionsperformed on Medicare beneﬁciaries. This 27% annualized
growth rate likely continued until 2011 (the year our data
were collected), and there were likely more patients treated
by endovascular means not necessitating a bypass or pa-
tients needing a bypass in whom previous endovascular
therapy had failed. This likely altered the dynamic of the
patients sampled from the NSQIP database for our study
compared with the earlier Nguyen et al analysis. The
NSQIP database does not allow us to evaluate failure of
endovascular therapy before LEB. Although we are unable
to distill this effect from our available data, this may be one
reason for the discrepancy of results.
LOS was signiﬁcantly higher among all black patients
and WF. This was clinically signiﬁcant, averaging >1 day
for black patients and almost half a day for WF. The etiol-
ogy of these results remains unclear. Although multivari-
able linear regression modeling was performed, signiﬁcant
preoperative comorbidities (ie, diabetes, renal insufﬁciency,
dialysis, less functional dependence, and critical limb
ischemia) may have contributed to the delay in discharge
postoperatively. LOS in LEB patients has not been well
evaluated in the literature, and further investigation into
these causes and ways to improve the quality of care in
our bypass patient population is warranted.
Biological factors might have inﬂuenced these out-
comes as far as inﬂammatory response to the bypass; how-
ever, distilling the inﬂuence of other social and
environmental factors on outcomes of LEB is very difﬁcult.
Other proposed factors leading to racial differences in out-
comes of LEB are access to health care, socioeconomic fac-
tors, education level, and compliance with medications. In
our analysis, BF and BM did have surgery for critical limb
ischemia compared with WM (P < .01 and P < .01, respec-
tively). This is potentially related to a delay in presentation;
however, this is unable to be assessed by the data set. These
and other factors are not controlled in this analysis, and the
synergistic race and gender effect on outcomes of LEB in
BF may be a marker for lower socioeconomic class.
There are certain limitations associated with this study.
First, the NSQIP data set did not allow us to monitor pa-
tient outcomes past the 30-day period; thus, our results
cannot be compared well against prior studies that have
looked at long-term outcomes.
Second, although the NSQIP data set does include a
large variety of variables, these are not speciﬁc to vascular
cases. Thus, vascular-speciﬁc surgical variables (primary
patency rate, secondary patency rate, vein size, etc) could
not be addressed. Whether these patients had endovascular
procedures before their interventions is also unclear.
Finally, some data were missing for important variables
related to outcomes, including critical limb ischemia and
history of peripheral vascular disease. For the purpose of
this analysis, these missing variables had to be imputed us-
ing the method of multiple imputations.
CONCLUSIONS
In our analysis of the 2011 NSQIP database, race and
gender were found to affect early graft failure and LOS
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economic factors from biological factors affecting graft fail-
ure and LOS in these race-gender subgroups undergoing
LEB. Aggressive preventative measures for peripheral
vascular disease targeting high-risk patient populations,
such as BF with peripheral vascular disease, as well as
further investigation into optimal methods of revasculariza-
tion based on demographics and comorbid conditions, is
warranted to improve individual patient outcomes.
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Submitted Feb 5, 2014; accepted Apr 29, 2014.DISCUSSIONDr Richard F. Neville (Washington, D.C.). Thank you very
much Mr Chairman. I would like to thank the Society for allowing
me to discuss this very interesting and provocative paper. Icongratulate the authors and Dr Jain on an excellent presentation.
This was a very interesting paper and, as many interesting papers
often do, raises more questions than it answers. Other groups
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Volume 60, Number 5 Jain et al 1281have looked at the impact of gender on vascular disease, and our
own group has looked at the racial distribution of lower extremity
occlusive disease. In fact, our current President and his group have
looked at distribution of disease based on race with clinical impli-
cation. Many studies indicate that there is some relationship,
whether related to genetics, socioeconomic factors, or some other
disease characteristic.
This morning the authors describe a study using the National
Surgical Quality Improvement Program (NSQIP) database to re-
examine racial distribution and complicate things by adding gender
into the mix. The authors report on 4500 lower extremity bypasses
and, as the NSQIP database allows, looked at perioperative results.
The authors note limitations with the NSQIP database, and I will
not belabor those. The study cohort included 3600 white patients
and 800 black patients (18%), with white males serving as the
referent or index group. Black patients had a higher incidence of dia-
betes, tobacco use, chronic obstructive pulmonary disease, end-
stage renal disease on dialysis, and presenting with chronic limb
ischemia. Other interesting points from the manuscript, which I
appreciate getting in a timely manner, included the white female
group presenting with more of an independent functional status.
As we have heard from another presentation earlier this morning,
functional status at presentation has its own implications. The black
female group was younger and presented with a lower hematocrit,
which our group has shown to have an impact on graft performance.
Also of note, the white male group had the most prosthetic grafts
used. Despite statistical challenges, the authors conclude that black
males had a higher length of stay, while black females had a higher
readmission rate and graft failure rate.
I have questions for the authors and would appreciate their in-
sights. The black female group was younger and with a lower he-
matocrit at presentation. Do you think this represents underlying
hypercoagulability or is this disease virulence? Were you able to
determine in the black female group with failed grafts a difference
in vein grafts or prosthetic grafts?
In terms of graft anatomy, NSQIP cannot differentiate above-
vs below-knee popliteal bypass, and yet you report above-knee vs
below-knee bypasses. Were you really talking about popliteal vs
tibial grafts? This might be an important point, were you able to
glean anything in terms of graft anatomy in the racial and gender
based results; popliteal vs tibial, or vein vs prosthetic? These arecomplex questions and we appreciate your response as it may
help guide us in clinical decisions. I appreciate the opportunity
to read the manuscript and congratulate you on an excellent
analysis.
Dr Ashish Jain. Thank you, Dr Neville, for your questions. I
will start with the question about the age of the black patient pop-
ulation. There have been several papers that discuss younger age
being associated with more virulent peripheral arterial disease,
and in lower extremity bypass being associated with early graft fail-
ure after surgery. In our data set, the average age of the black pa-
tients was about 65. Previous papers showing worse outcomes in
younger patients were referring to younger ages below 60 or
50 years old. The black patients in our group are considerably
older, so they would not be considered young.
Secondly, if you look at our patient sample size, the black
males were actually younger than the black females. While the
black patients in general were younger than the white patients,
we did not see any speciﬁc impact of that result on the black
male group. If age was contributing a lot to this, then we were
at least thought to have seen a little bit more of an impact on
the black male group as well. This certainly does not say that age
is not associated with early outcomes, and I certainly do agree
that age may play a major role in peripheral arterial disease.
What it does show is that black females have something speciﬁc
about their own make-up and their own dynamic that is different
from other race-gender subgroups despite age.
Looking at the second question about tibial disease, so our pa-
tient group was divided 50/50 for black patients that underwent
popliteal vs tibial bypass. Amongst white patients, it was a little
bit more skewed towards white males undergoing more popliteal
bypass. When we look at this with the black patients having about
a 50/50 split, we did not really see a difference between the two
different race-gender strata between black females and black males
in their outcomes. White females seem to have fewer tibial by-
passes, but they also were not signiﬁcantly different compared to
the white males with regards to their postoperative endpoints.
So while I do agree that popliteal and tibial bypasses may in
general impact outcomes, in our data they are not major factors
affecting race-gender differences. This again shows that there is
something speciﬁc about the race-gender subgroup of black fe-
males that is associated with a higher risk of a graft failure.
